Attenuation of angiotensin II-mediated coronary vasoconstriction and vasodilatory action of angiotensin-converting enzyme inhibitor in pacing-induced heart failure in dogs

Journal of the American College of Cardiology

Volumn 38, Issue 4, 2001, Pages 1188-1194

  Oikawa, Yuji ^a   Maehara, Kazuhira ^a   Saito, Tomiyoshi ^a   Tamagawa, Kazuaki ^a   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN; ANGIOTENSIN ANTAGONIST; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL HEART PACEMAKER; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; DOG; DRUG EFFECT; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEMODYNAMIC MONITORING; NONHUMAN; PRIORITY JOURNAL;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BRADYKININ; CORONARY VESSELS; DOGS; FEMALE; HEMODYNAMIC PROCESSES; MALE; VASCULAR RESISTANCE; VASODILATION;

EID: 0034806666     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01494-2     Document Type: Article

References (37)

1. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain
2. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomopathy
3. Alternations in vasomotor tone in congestive heart failure
4. Preload-induced alterations in capacitance-free diastolic pressure-flow relationships
5. Pressure-flow relations in coronary circulation
6. Effects of the pericardium on the diastolic left coronary, pressure-flow relationships in the isolated dog heart
7. Effect of synchronized retroperfusion on coronary arterial pressure-flow relationship
8. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with renin-angiotensin system and the sympathetic nervous system
9. Responses of plasma norepinephrine and renin-angiotensin-aldosterone system to dynamic exercise in patients with congestive heart failure
10. B receptor antagonists in congestive heart failure
11. Effects of enalaprilat on mortality in severe congestive heart failure
12. Effects of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure
13. Randomized trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
14. Coronary and myocardial actions of angiotensin
15. Selective downregulation of angiotensin II AT-1 subtype in failing human ventricular myocardium
16. Coronary vasodilation induced by intracoronary enalaprilat: An argument for the role of a local renin-angiotensin system in patients with dilated cardiomyopathy
17. Rapid pacing in the dogs: Pathophysiologic studies of heart failure
18. Increased production of nitric oxide in coronary arteries during congestive heart failure
19. Reduced NO-dependent arteriolar dilation during the development of cardiomyopathy
20. A simple technique for production of chronic complete heart block in dogs
21. Fluorogenic reagents for the derivatization of catecholamines and related compounds for liquid chromatographic analysis of biochemical samples
22. A method of radioimmunoassay of plasma angiotensin II using fluoroil
23. Stability of human atrial natriuretic peptide in blood samples
24. Presence of immunoreactive endothelin in human plasma
25. In vivo pharmacology of L-158,809, a new highly potent and selective non-peptide angiotensin II receptor antagonist
26. Blockade of the renin-angiotensin system in heart failure in conscious dogs
27. Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo
28. Left ventricular volume and mass from single-plane cineangiocardiogram: A comparison of anteroposterior and right anterior oblique methods
29. Influence of autoregulation and capacitance diastolic coronary artery pressure-flow relationships in the dog
30. Effect of selective angiotensin II receptor antagonism and angiotensin-converting enzyme inhibition on the coronary vasculature in vivo
31. 2-receptor mediates inhibition of cell proliferation in coronary endotherial cells
32. Altered ventricular and myocyte responses to angiotensin II in pacing-induced heart failure
33. Angiotensin-converting enzyme inhibitors promote nitric oxide production in coronary microvessels from falling explanted human hearts
34. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure
35. Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure
36. Alteration of endothelium-dependent and -independent regulation of coronary circulation of duration of pacing-induced heart failure
37. Endothelium-dependent vasomotor response to endogenous agents are potentiated following ACE inhibitor by bradykinin-dependent mechanism